Oxidative phosphorylation disorders make a contribution of 1 per 10,000 liv
e births in man, of which isolated complex I deficiency is frequently the c
ause. Complex I, or NADH:ubiquinone oxidoreductase, is the largest multi-pr
otein enzyme complex of the mitochondrial electron transfer chain. In compl
ex I deficiency, various clinical phenotypes have been recognized, often re
sulting in multi-system disorders with a fatal outcome at a young age. Rece
nt advances in complex I deficiency, regarding clinical, biochemical, and m
olecular aspects are described. However, the genetic causes of about 60% of
complex I deficiency remain unclear. As a consequence, further research wi
ll be needed to clarify the genetic defects in the remaining cases. Novel s
trategies in which interesting non-structural nuclear-encoded disease-causi
ng genes may be found, as well as the molecular genetic composition of huma
n complex I, are presented. (C) 2001 Wiley-Liss, Inc.